» Articles » PMID: 15323147

Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency of MLL Gene Translocation: Results in 378 Adult Patients

Overview
Specialty Pathology
Date 2004 Aug 25
PMID 15323147
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Structural abnormality of the 11q23 band (11q23+) bearing the MLL gene translocation (MLL+) is a recurrent chromosome change observed in 3% to 7% of acute lymphoblastic leukemias and in 3% to 4% of acute myeloblastic leukemias. The resolution of conventional cytogenetics (CC) in detecting 11q23 rearrangement is limited when the translocative partner has a telomeric location; furthermore, CC can barely discriminate between true 11q23+/MLL+ and rearrangements clustering within the 11q22 to approximately 25 region without MLL involvement (MLL-). We characterized a series of 378 consecutive patients with adult acute leukemia by using CC, fluorescence in situ hybridization (FISH), and multiplex karyotyping (M-FISH) analysis. Our aim was to define the frequency of cryptic MLL+ cases and the frequency of MLL+ within 11q22 to approximately 25+ cases. As expected, FISH was more sensitive than CC in detecting MLL+ cases, but rather unexpectedly, 9 (45%) of 20 patients with 11q22 to approximately 25+ were MLL-. A better characterization of 11q22 to approximately 25+/MLL- leukemias is relevant for the identification of new, recurrent translocations. Moreover, these cases should be readily distinguishable from 11q23+/MLL+ cases. We recommend that karyotypic analysis always be complemented by molecular or FISH methods to unravel MLL rearrangements.

Citing Articles

Genomic Characterization of Partial Tandem Duplication Involving the Gene in Adult Acute Myeloid Leukemia.

Seto A, Downs G, King O, Salehi-Rad S, Baptista A, Chin K Cancers (Basel). 2024; 16(9).

PMID: 38730645 PMC: 11082951. DOI: 10.3390/cancers16091693.


Prevalence of Gene Rearrangement by Multiplex PCR in De Novo Acute Myeloid Leukemia in Adult Iraqi Patients.

AlJabban A, Alalsaidissa J J Blood Med. 2023; 14:445-453.

PMID: 37588276 PMC: 10426445. DOI: 10.2147/JBM.S416825.


Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.

Issa G, Zarka J, Sasaki K, Qiao W, Pak D, Ning J Blood Cancer J. 2021; 11(9):162.

PMID: 34588432 PMC: 8481264. DOI: 10.1038/s41408-021-00557-6.


Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity.

Rogawski D, Deng J, Li H, Miao H, Borkin D, Purohit T Nat Commun. 2021; 12(1):2792.

PMID: 33990599 PMC: 8121805. DOI: 10.1038/s41467-021-23152-6.


A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia.

Ozyerli-Goknar E, Nizamuddin S, Timmers H ChemMedChem. 2021; 16(9):1391-1402.

PMID: 33534953 PMC: 8252030. DOI: 10.1002/cmdc.202000972.